![Daqing Cai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daqing Cai
Directeur/Membre du Conseil chez
Beijing Shenogen Pharma Group Ltd.
Profil
Daqing Cai is currently Director at Appia Bio, Inc. and Beijing Shenogen Pharma Group Ltd., and Managing Partner at Zhuhai Sherpa Equity Investment Management Co. Ltd. Former positions include Managing Director at Legend Capital Co. Ltd. from 2015 to 2018, Independent Director at Bionano Genomics, Inc. from 2014 to 2019, Director roles at Innovent Biologics, Inc., Indi Molecular, Inc., and Axonics, Inc., and Chief Financial Officer & Director at Beijing Genomics Institute from 2014 to 2016.
Education includes an MBA from Yale University, a doctorate from the University of California, Berkeley, and an undergraduate degree from the University of Science & Technology of China.
Postes actifs de Daqing Cai
| Sociétés | Poste | Début |
|---|---|---|
Beijing Shenogen Pharma Group Ltd.
 Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Manufactures icaritin drug products | Directeur/Membre du Conseil | - |
Appia Bio, Inc.
 Appia Bio, Inc. BiotechnologyHealth Technology Develops cell therapies | Directeur/Membre du Conseil | - |
Zhuhai Sherpa Equity Investment Management Co. Ltd.
 Zhuhai Sherpa Equity Investment Management Co. Ltd. Investment ManagersFinance Acts as an alternative investment manager | Private Equity Investor | - |
Anciens postes connus de Daqing Cai
| Sociétés | Poste | Fin |
|---|---|---|
| BIONANO GENOMICS, INC. | Directeur/Membre du Conseil | 21/08/2019 |
Legend Capital Co. Ltd.
 Legend Capital Co. Ltd. Investment ManagersFinance Legend Capital invests in companies located in China. The firm targets companies operating in the fields of technology, healthcare, consumer, enterprise service and intelligent manufacturing sectors. It provides financing for early and growth stage capital requirements. | Corporate Officer/Principal | 01/04/2018 |
Beijing Genomics Institute
 Beijing Genomics Institute BiotechnologyHealth Technology Develops science and technology services in genomics field | Directeur Financier/CFO | 01/01/2016 |
Indi Molecular, Inc.
 Indi Molecular, Inc. BiotechnologyHealth Technology Develops a synthetic class of diagnostic and therapeutic agents | Directeur/Membre du Conseil | - |
| INNOVENT BIOLOGICS, INC. | Directeur/Membre du Conseil | - |
Formation de Daqing Cai
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
53
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Science & Technology of China
 University of Science & Technology of China Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Legend Capital Co. Ltd.
Legend Capital Co. Ltd. Investment ManagersFinance Legend Capital invests in companies located in China. The firm targets companies operating in the fields of technology, healthcare, consumer, enterprise service and intelligent manufacturing sectors. It provides financing for early and growth stage capital requirements. | Finance |
Bionano Genomics, Inc.
 Bionano Genomics, Inc. BiotechnologyHealth Technology Develops technologies for analysis of large biological molecules | Health Technology |
Innovent Biologics, Inc.
 Innovent Biologics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Indi Molecular, Inc.
Indi Molecular, Inc. BiotechnologyHealth Technology Develops a synthetic class of diagnostic and therapeutic agents | Health Technology |
Axonics, Inc.
 Axonics, Inc. Medical SpecialtiesHealth Technology Engages in design, development and commercialization of neuromodulation solutions | Health Technology |
Beijing Genomics Institute
Beijing Genomics Institute BiotechnologyHealth Technology Develops science and technology services in genomics field | Health Technology |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Manufactures icaritin drug products | Health Technology |
Zhuhai Sherpa Equity Investment Management Co. Ltd.
Zhuhai Sherpa Equity Investment Management Co. Ltd. Investment ManagersFinance Acts as an alternative investment manager | Finance |
Appia Bio, Inc.
Appia Bio, Inc. BiotechnologyHealth Technology Develops cell therapies | Health Technology |
